text:
New To Do
New To Do
Try something different. As the saying goes, Ïf you're not learning you're not living. Get out there and try something new! Never been fond of mud season? Learn to love it! Never took the time to learn your constellations? Well, now is the time! Get ideas for expanding your camping horizons.
How to Make an Igloo
How to Make an Igloo
Building an igloo is a great way to spend a day enjoying the snow. You will need to be prepared to work hard, but if you do you will have a lot of fun. Building an igloo is a fabulous way to enjoy and spend some good quality time with friends and family.
To build an igloo you will need a few tools, you will need a nice cold, snowy area, a shovel or snow spade, a saw and possibly a ski. After you have your materials you will need to find an appropriate spot to build your igloo. The spot you choose should have a nice hard snow field to build the igloo and cut the blocks to make the igloo. Where you finally decide to place your igloo, the snow should be about 3 feet deep.
Draw a circle in the snow at the spot where you will build your igloo. Don't make the circle too big, or your igloo will be too big and unstable. You want you igloo to fit about 3 people at the maximum. Use your saw to cut the blocks for your igloo. Don't cut the blocks in the spot where you have draw your circle. Your blocks should be about 6 to 12 inches thick, and not so big that they break when carried. The blocks for the base should be larger than the blocks for the top.
When you have your blocks cut out, you can start building your igloo. Place the larger blocks in at the base on your drawn out circle. At one point in your circle you will need to make an opening, the door to your igloo. To make the door, place two blocks perpendicular to your base blocks. Complete the door by placing another block horizontally over the other door blocks.
Once you have your base set of blocks laid, you will need to cut an angle into the blocks. To make this easier, you can place a ski in the center of your igloo and cut an angle into the top of your base layer of blocks. If you don't cut the angle into your blocks you will end up building a tower. The angle sets up the curve that creates the dome shape of the igloo. Add a few more layers of blocks to your igloo.
At some point you will need to dig out the floor of your igloo, as well as dig out the floor of the door. Digging out the floor will increase the head room in your igloo. As you continue adding layers of blocks. As you build, you will want to continue cleaning out the floor of the igloo.
When you get to the topmost layers of blocks you might want to use a stick to prop up the top if you are worried about stability. When you get to the final block to finish the dome you will need to pull the block in through the door and place it from the inside.
To finish the igloo pack the cracks, there will be a few, with snow. From the inside you will want to smooth out the walls. Once your cracks are filled and your walls are smooth you are ready to enjoy your newly made igloo.
- Category: New To Do
More Articles ...
- Go Wine Tasting
- Grape Stomping
- Campfire Cooking | Clambakes
- Hot Air Ballooning
- How To Make Lavender Wands
- Winter Wildlife Viewing
- How to Make Birdseed Balls
- Audubon Holiday Bird Count
- Winter Trail Walks
- Storm Watching on the Pacific Coast
- Real Haunted Houses
- Berry Picking
- Homemade Cider
- State Fairs
- Canoe Camping
- See the Chincoteague Wild Horses
- At-Home Spa Treatments
- Taking a Bike Trip
- Get Better Gas Mileage
- Nighttime Activities
- Build Your Own Kite
- RV Trip to Baseball's Spring Training Destinations
- Enjoying Mud Season
- Brew Your Own
- Going Solo
- Meditation and Yoga
- Make Your Own Wine
- Bird Watching
- Stargazing
- How to Make a Piñatas
- Hunt for Mushrooms and Truffles
- Wildflower Walks
- Campfire Cooking
- Ghost Towns
- Making Ice Cream
- U-Pick Berries
- Rediscover Roller Coasters
- Panning for Gold
- Apple Picking
- Hiking Historic Trails
- Ice Fishing
- Polar Bearing


text:
In May 2006, medical regulators in Denmark issued a warning that signaled trouble for General Electric. Danish researchers noted that, over a four-year period, 25 patients in Denmark and Austria had suffered a rare and crippling disease after undergoing an MRI, the scanning procedure used to diagnose everything from brain tumors to blown knees. The patients had been injected with a GE dye that makes images more distinct. They all had weak kidneys before receiving the dye.
The GE product, Omniscan, has since been linked to other cases of the disease, which appears to affect only MRI patients who have kidney problems. Similar drugs made by Bayer and others have also been tied to the sometimes fatal ailment, nephrogenic systemic fibrosis (NSF).
Some regulators and researchers in the U.S. and Europe have found that a disproportionate number of NSF cases are associated with GE's Omniscan. That threatens to create a costly liability mess for the company's growing $17 billion health-care division, which GE promotes heavily with its "Healthymagination" ad campaign. The company's diagnostic products generate about $1.8 billion in sales. GE doesn't provide financial figures on Omniscan.
People with NSF, or relatives of those who have died, have filed more than 400 lawsuits in U.S. federal courts against GE, Bayer and two other makers of similar drugs in the past several years. About 100 cases don't concern Omniscan. Of the roughly 300 that do involve the GE drug, about 70 percent relate exclusively to Omniscan, according to court records and lawyers on both sides. Bayer HealthCare has some 50 percent of the U.S. market, regulators estimate. GE is next, with about 30 percent.
While GE says it is investigating concerns about Omniscan, the company maintains there is no proof that the drug, known as a contrast agent, causes disease. "NSF is a complex disease with a number of contributing factors," GE said in a February 2009 position paper. It conceded that a critical ingredient in Omniscan and other agents may be one of those factors, "but not necessarily an essential" factor. Scientists concur that they don't fully understand how the disease starts, although nearly all cases have involved patients with kidney problems who were injected with MRI contrast agents.
The U.S. Food and Drug Administration has required since May 2007 that makers of contrast agents use a stern "black box" warning cautioning physicians to weigh carefully the benefits and risks for patients with weak kidneys. Screening out people with kidney problems appears to eliminate the danger of NSF. But the FDA has not said that GE's product is any more problematic than those of its competitors. The agency reached that conclusion even after two of its staff doctors — in findings disclosed here for the first time — determined that Omniscan is riskier than its rivals. GE had urged the FDA to treat all of the agents as equally risky.
Now one of the nation's leading imaging-safety experts, Dr. Emanuel Kanal, a professor at the University of Pittsburgh Medical Center, says the FDA's decision to lump all contrast agents together is "inappropriate and indefensible." Kanal warns that the government's position potentially "endangers American citizens." The FDA, while defending its stance, says it will meet with Kanal to look at fresh data. (Kanal isn't working for any of the parties in the lawsuits.)
A spokesman for GE Healthcare, Ryan Fitzgerald, declined to comment specifically on the litigation or the FDA's position on contrast agents. GE is "confident" in its "legal positions," he added. On its corporate Web site, the company says Omniscan is superior to rival contrast agents because its "low viscosity" makes it easier to inject.
(GE Healthcare issued a response on Oct. 16, in which it said this story "unfairly characterizes GE's relationships with its customers.")
The companies that have been sued deny liability. In recent months, Bayer HealthCare has settled more than 100 cases related to its contrast agent, Magnevist, according to lawyers and court records. The terms have been kept confidential. Plaintiffs in the GE cases have not formally specified the total damages they are seeking. Their lawyers calculate a potential mass resolution could cost the conglomerate $1 billion. GE called the figure "a speculative and self-interested claim that is not supported by the facts."
The suspected culprit
Some prominent physicians applaud the company's efforts to cooperate. Dr. Jeffrey C. Weinreb is a Yale School of Medicine professor of diagnostic radiology who has consulted with GE. "As far as I can tell," he says, the company "made a good-faith effort to provide relevant information" to medical professionals about Omniscan and the incidence of NSF. But Yale-New Haven Hospital, where Weinreb practices, has had several NSF patients die in recent years, he adds, and decided "to play it safe" and stop buying Omniscan in late 2006.
Omniscan and comparable products contain the potentially toxic metal gadolinium. During MRIs, the metal helps physicians see the brain and other parts of the body. Healthy kidneys filter out gadolinium. But patients with severely impaired kidneys can become victims of NSF, according to the FDA.
NSF starts with painful swelling in the legs and arms. It progresses to lesions in the skin and connective tissues, and it can attack organs, causing death. So far, there is no cure.
GE got into the contrast-agent business in 2004, when it acquired Amersham, a British maker of scanning drugs. About a week after the Danish Medicines Agency issued its international alert, GE Healthcare sent a letter to physicians acknowledging the Danish findings but stressing that the company was committed to keeping patients safe and informed. GE noted that Omniscan had been used 30 million times since its introduction in 1993. A "causal relationship" between NSF and gadolinium-based contrast agents "has not been established," the company said.
By early 2007, however, regulators across Europe and in Japan were scrutinizing contrast agents. Omniscan appeared to be linked with more reported cases of NSF than its market share would have predicted, some regulators found. That March, the American College of Radiology, the professional group for doctors who administer imaging scans, issued guidance that Omniscan posed a greater risk than rival products.
The radiologists' warning contributed to decisions by several large hospitals in New York, Pennsylvania, and elsewhere to stop buying Omniscan. GE responded to the marketing challenge by making it easier for hospitals to receive financial incentives if they continued to purchase some Omniscan, according to court records and hospital executives.
Dissent within the FDA
In March 2007, GE published a position paper arguing that its diligence in encouraging reporting of NSF cases had created a "probable bias" in data showing the relatively large number of Omniscan-associated illnesses, compared with those involving competitors' products. The paper cast the NSF problem as possibly relating to the entire class of gadolinium agents. Omniscan and competing agents should be avoided, GE said, "unless the benefit clearly outweighs the risks."
The FDA, meanwhile, was receiving an increasing number of reports of NSF, records show. In 2007 two agency doctors raised concerns about Omniscan. The FDA assigned Dr. Melanie Blank, a kidney specialist, to review the safety of all contrast agents. Blank's report concluded that an "undeniable and strong association" existed between contrast agents containing gadolinium and NSF. In an interview, she said she found that medical and sales data indicated Omniscan "had most of the cases and less of a share of the market, so I believed Omniscan was the worst player."
Another FDA staff member, Dr. Louis Marzella, did a separate review of Omniscan. In an April 6, 2007, report, Marzella said "a contraindication for Omniscan is warranted" for patients with severe kidney disease. A contraindication has the effect of banning certain uses of a drug, regardless of the possible benefits.
GE repeatedly provided information on Omniscan to the FDA, as drug manufacturers routinely do. GE officials "knew we knew most of the cases were with them," Blank says.
In May 2007, the FDA ordered makers of all contrast agents to change their labels and highlight, in a prominent black box, the risks of NSF. The agency did not contraindicate the drugs for any patient. The FDA news release on the labeling change listed Omniscan as the drug most frequently associated with NSF cases, followed by Bayer's Magnevist. The agency didn't provide actual numbers of cases.
R. Dwaine Rieves, as head of the FDA's imaging division, was ultimately responsible for the decision to issue an across-the-board warning. He says he was influenced by an April 19 meeting at which senior FDA officials questioned the adequacy of data associating NSF with Omniscan. "What entered into our decision," he says, "was a very limited database."
After the FDA issued its blanket warning, GE reinstated requirements that customers purchase certain minimum amounts of Omniscan in order to receive financial incentives, according to Kathryn E. Goldstein, a spokeswoman for Novation, a purchasing organization for 25,000 health-care providers. Kanal, the Pittsburgh medical professor, says he confronted GE managers over what he considered their "inappropriate" decision to induce customers to buy Omniscan. Fitzgerald, the GE spokesman, confirmed the switch in financial incentives but declined to address Kanal's criticism.
Kanal, who heads a blue-ribbon panel on magnetic resonance safety for the American College of Radiology, says he is pressing the FDA to analyze a public database created by plaintiffs and manufacturers in the NSF litigation, among other new information. The FDA's Rieves has agreed to meet with Kanal on Oct. 20 and says he is receptive to new data: "We want to see it."

subset: commoncrawl


text:
Premium Market Insights reports titled "Marine Engines Market" and forecast to 2027 gives a detailed analysis of the market with key company profiles. Marine Engines market is evaluated based on two segments i.e., by type and application and covers essential statistics and details for current and future market scenarios. The report actively includes informative aspects relating to product developments, launches, and trends, to assist market players, shareholders, and investors in strategic decision making.
Check for the sample here – https://bit.ly/2ytL7Bs
The report also puts forward the current and future market scenario derived precisely from a thorough analysis of the markets across five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The exhaustive PEST analysis is done for each region to assess major external factors which may influence Marine Engines Market in the coming years.
The market study also includes the key drivers expected to boost the market growth and restraining factors along with future opportunities during the forecast. Marine Engines Market is likely to showcase symbolic growth opportunities owing to growing demands for Industrial Wax across the globe. The market report highlights top ten companies' operation strategy in the market through a descriptive SWOT analysis of each company, business overview, products and services, financial statements of last three years, and key developments and product launches by the company in recent years.
The List of companies covered in this Reports are:
1. AB Volvo
2. Caterpillar
3. Cummins Inc
4. Deere and Company
5. Deutz AG
6. Hyundai Heavy Industries [ Engine and Machinery Division]7. Kongsberg Maritime
9. Mitsubishi Heavy Industries Marine Machinery and Equipment Co. , Ltd.
10. Wartsila
The insights also cover the production, value, market share, and growth rate of these top manufacturers and investigate the competitive landscapes for a better understanding of the market scenario. The report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities accordingly.
For Purchase this report: https://www.premiummarketinsights.com/buy/TIP00012271
Contact Info:
Name: Sameer Joshi
Email: email@example.com
Organization: Premium Market Insights
Phone: +1-646-491-9876
About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.
This release was published on openPR.


text:
Most importantly, we like to receive current titles in excellent condition.
These are the material we love to get:
For more information please email the library or call at 307-733-2164.
Show All Answers
Sometimes the donated item doesn't meet the Library's collection development criteria. Perhaps we already have enough copies of the donated title, or enough information of the subject, or it may not meet the information needs of our community. If the Library can't use the item, it gets passed along to the Teton County Library Friends.
The Friends sort the items and put them into the Friends Book Nook in the library lobby. Friends' mission is to get as many books as possible into as many hands as possible for as little money as possible.
Donated items not added to the collection or to the Book Nook are passed on to the community.
Library Main Desk staff will be happy to give you a receipt for the number of items donated and the date of the donation. However, we are unable to quote a value for donated items.
We are not able to accept:
Teton County Recycling accepts magazines, hardcover books, and paperbacks.
The most important role of Teton County Library Friends is to support the Library through volunteerism and advocacy. The main focus of the Teton County Library Foundation is to raise money from donors like you to make possible Library enrichments such as the following:


text:
"This project started with a 1/6th scale RC Hummer from NewBright Toys . The idea was to build a fully functioning gaming computer – but to also be able to unhook all the peripherals and drive the truck around, when I got bored and needed a break."
this mod is off the hook. thanks for the link filtronic.


text:
Wayde Fawcett, DDS
June 2, 2020 by Assistant Editor
Filed under Fawcett, Wayde, DDS, Top Dentists
Wayde Fawcett, DDS
Cosmetic Dentistry & Dental Implants
Dr. Fawcett has been providing a wide range of services in general dentistry in his hometown for over 36 years, with a special focus on cosmetic dentistry, dental implants and full smile makeovers.
One of the most popular procedures he offers is Teeth-In-One-Day, a groundbreaking alternative that allows patients to receive dental implants and a full set of new teeth all in the same day. "We provide dentistry that changes people's lives, and in doing so, we change our own," says Dr. Fawcett. "Our commitment to quality governs every aspect of our work and ensures that we always exceed our clients' expectations."
In 2007, Dr. Fawcett was among 157 dentists to be honored with the title "Master of the Academy of General Dentistry (MAGD)," considered to be one of the most respected designations in the profession. Most recently, in 2015, Dr. Fawcett received the prestigious Lifelong Learning and Service Recognition from The Academy of General Dentistry (AGD), a distinction held only by 274 of the ADG's 39,000 members, recognizing his commitment to continuing education, community service and mentorship.
Clients of Dr. Fawcett appreciate the personal attention, warmth and genuine concern he shows each individual. His fun-loving personality and compassionate chairside manner have nurtured long-lasting relationships and loyal patients from all over the world.
SERVICES: Teeth-In-One-Day • Implants • Cosmetic Dentistry • Full Mouth Rejuvenation • Smile Makeovers • Porcelain Veneers & Crowns • Porcelain Bridges & Partials • Sleep Dentistry • Gum Disease & Hygiene Programs • TMJ /Neuromuscular Dentistry • Sleep Apnea
EDUCATION: University of Texas Dental School, Houston, TX
ACCREDITATIONS: Master of the Academy of General Dentistry (MAGD) • Fellow of the International Congress of Oral Implantologists (FICOI) • Graduate of the Las Vegas Institute for Advanced Dental Studies (LVI)
Fawcett Center for Dentistry
13956 Cutten Road
Houston, TX 77069
281-440-6648 • DrFawcett.com


text:
Topic: Avatar rating
You know when you get an avatar, but you aren't sure how great it is and need someones oppinion. Well, this topic is just for that! When you get a new avatar, whether you made it or someone else did, just post here and others will critique and rate it.
But there is one real rule. Don't request to get your avatar rated without rating at least one other person's avatar in the same post. This way we can make sure that everyone can get a fair number of ratings.
Since we need someone to start us off, rate my new avatar. It's Ron Stoppable from Kim Possible if you didn't recongize it.


text:
Related links:
Desert Mammals
There are many species of mammals in the desert! Many of them dig holes in the ground to live in. These holes are called burrows. Rats and hamsters live in burrows.
Bigger mammals, like the wild horse, live in the desert too. Lions are strong animals that live in Africa. The spiny anteater is a special mammal because it lays eggs!
Most mammals hide during the day to stay cool. They come out at night to find food.


text:
Sonic scientist Peter Neubäcker of Melodyne has been wowing Internet audiences for some time with the automagical powers of the company's Direct Note Access (DNA). The vision: manipulate individual pitches as easily as MIDI notes, even in polyphonic passages of a single instrument. At NAMM last month, the company showed the first product, Melodyne editor, due to ship in the spring for US/EUR 349.
There's just one little catch: a solo developer has beaten them to the punch, at least prior to them shipping their DNA flagship editor tool. And if you want it right now, it's yours for 25 Euros. (The final version will cost 99 Euros.)
Jonathan Schmid-Burgk, sole developer and a student at Harvard, announces:
The time has come to announce the release of the world's first published polyphonic tone manipulation software. The dream of musicians to isolate single notes out of chords and so to manipulate most forms of recorded audio has come true on the 20th of January 2009.
Shell out EUR25, and you get a Mac VST plug-in that can manipulate audio easily. With monophonic audio, you can create polyphonic harmonizations. You can isolate and manipulate individual harmonics – meaning not only can you do pitch manipulations, but presumably sound design, as well. You can change individual notes or chords in recorded audio, to fix mistakes or (more interesting) actively recompose audio.
I feel about this the same way I do about Celemony: this gets really interesting when you use it for sound design. For some inspiration, skip this post and head straight for the sound samples on the site:
VisualVox polyphonic 0.9 [improvisator.de]
Via the awesome rekkerd.org
Also check out his Harmony Improvisator which creatively generates harmonies from MIDI input – an interesting thing to mess around with even for those of us who know / have taught (ahem) classical harmonic theory
Now, VisualVox Polyphonic isn't without some catches, as you'd expect from the solo-student cheap alternative:
- It's Mac-only and VST-only for now. (Just keep in mind, though, that means not only Cubase works but things like Ableton Live on the Mac, as well.)
- Jonathan warns that there are still some bugs, there are big temporary files, there are occasional glitches in the algorithm, and it doesn't quite sync properly with hosts, requiring exports.
- The interface isn't as slick or fancy as Celemony, and may be slightly less convenient for editing.
- Update – people are having some significant hosting issues with this. (Your mileage may vary, though the fact that this was tested in Cubase tells me those folks may have better luck.) So stay away if you don't like bugs – this isn't a final release. We'll have more as this evolves, okay?
But here's why I'm anxious to test it, nonetheless:
- It's cheap – meaning it might be more open to people just curious to experiment. (I actually wonder if he shouldn't keep the EUR25 price and make up for it on volume.)
- No iLok dongle, as required for Celemony. Correction: Celemony also allows challenge/response — so you have a choice.
- There are some interesting fine-tuning options for the algorithm and manipulation parameters. That could make this more interesting for sound design – and something even Celemony users might want to run alongside the more polished tool.
In other words, none of this is likely to dampen enthusiasm for Celemony, but that's a good thing: more is more better. Could this mean the floodgates are about to open for creative sound design tools that mess with audio in new ways? Hey, I hope so.
If anyone tests this, we'd love your report – and sound examples.